Josep Llorens is EVP, Global Manufacturing of HAEMONETICS CORP. Currently has a direct ownership of 30,940 shares of HAE, which is worth approximately $2.4 Million. The most recent transaction as insider was on May 28, 2024, when has been sold 4,510 shares (Common Stock) at a price of $95.73 per share, resulting in proceeds of $431,742. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.9K
0% 3M change
67.58% 12M change
Total Value Held $2.4 Million

Josep Llorens Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 28 2024
SELL
Payment of exercise price or tax liability
$431,742 $95.73 p/Share
4,510 Reduced 12.72%
30,940 Common Stock
May 28 2024
BUY
Grant, award, or other acquisition
-
14,140 Added 28.51%
35,450 Common Stock
May 20 2024
SELL
Open market or private sale
$93,843 $95.08 p/Share
987 Reduced 4.43%
21,310 Common Stock
May 17 2024
SELL
Payment of exercise price or tax liability
$30,633 $95.73 p/Share
320 Reduced 1.96%
16,030 Common Stock
May 17 2024
SELL
Open market or private sale
$77,942 $94.82 p/Share
822 Reduced 4.79%
16,350 Common Stock
May 17 2024
BUY
Grant, award, or other acquisition
-
6,267 Added 21.94%
22,297 Common Stock
May 16 2024
SELL
Payment of exercise price or tax liability
$24,932 $94.8 p/Share
263 Reduced 1.44%
17,942 Common Stock
May 16 2024
SELL
Open market or private sale
$74,027 $96.14 p/Share
770 Reduced 4.29%
17,172 Common Stock
May 15 2024
SELL
Payment of exercise price or tax liability
$24,894 $96.49 p/Share
258 Reduced 1.4%
18,205 Common Stock
Jul 18 2023
SELL
Open market or private sale
$443,520 $90.0 p/Share
4,928 Reduced 21.07%
18,463 Common Stock
Jul 18 2023
BUY
Exercise of conversion of derivative security
$281,290 $57.08 p/Share
4,928 Added 17.4%
23,391 Common Stock
May 18 2023
SELL
Payment of exercise price or tax liability
$118,592 $83.34 p/Share
1,423 Reduced 7.16%
18,463 Common Stock
May 16 2023
SELL
Payment of exercise price or tax liability
$28,457 $89.21 p/Share
319 Reduced 1.58%
19,886 Common Stock
May 15 2023
BUY
Grant, award, or other acquisition
-
3,084 Added 13.24%
20,205 Common Stock
May 12 2023
SELL
Payment of exercise price or tax liability
$9,962 $88.16 p/Share
113 Reduced 0.66%
17,121 Common Stock
Jan 23 2023
SELL
Open market or private sale
$215,190 $90.0 p/Share
2,391 Reduced 12.18%
17,234 Common Stock
Jan 23 2023
BUY
Exercise of conversion of derivative security
$135,258 $56.57 p/Share
2,391 Added 10.86%
19,625 Common Stock
Sep 06 2022
SELL
Open market or private sale
$7,452 $73.78 p/Share
101 Reduced 0.58%
17,234 Common Stock
May 19 2022
SELL
Open market or private sale
$83,804 $59.1 p/Share
1,418 Reduced 7.56%
17,335 Common Stock
May 16 2022
SELL
Open market or private sale
$6,003 $56.1 p/Share
107 Reduced 0.74%
14,413 Common Stock
May 16 2022
BUY
Grant, award, or other acquisition
-
4,340 Added 18.79%
18,753 Common Stock
Sep 07 2021
SELL
Open market or private sale
$6,461 $64.61 p/Share
100 Reduced 0.68%
14,520 Common Stock
May 19 2021
SELL
Open market or private sale
$6,899 $55.19 p/Share
125 Reduced 0.85%
14,620 Common Stock
May 18 2021
BUY
Grant, award, or other acquisition
-
10,605 Added 41.83%
14,745 Common Stock
May 17 2021
SELL
Open market or private sale
$6,381 $55.97 p/Share
114 Reduced 2.68%
4,140 Common Stock
JL

Josep Llorens

EVP, Global Manufacturing
Boston, MA

Track Institutional and Insider Activities on HAE

Follow HAEMONETICS CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HAE shares.

Notify only if

Insider Trading

Get notified when an Haemonetics Corp insider buys or sells HAE shares.

Notify only if

News

Receive news related to HAEMONETICS CORP

Track Activities on HAE